Cash, Cash Equivalents, Marketable Securities, and Restricted Cash (Tables)

12 Months Ended

Dec. 31, 2023

Cash and Cash Equivalents [Abstract]

Schedule of Cash and Cash Equivalents

The following table summarizes the Company's cash and cash equivalents and marketable investments (in thousands) as of December 31, 2022:

December 31, 2022	Amortized Cost		Gross Unrealized Gains		Gross Unrealized Losses		Fair Market Value
Cash and cash equivalents	N/A		N/A		N/A		$	145,924
Current restricted cash	N/A		N/A		N/A		700
Cash, cash equivalents, and restricted cash as reported within the Consolidated Statements of Cash Flows	N/A		N/A		N/A		146,624
Marketable investments - U.S. Treasury	171,484		8		(102)		171,390
Total	$	171,484	$	8	$	(102)	$	318,014

Schedule of Restricted Cash and Cash Equivalents

The following table summarizes the Company's cash and cash equivalents and marketable investments (in thousands) as of December 31, 2022:

December 31, 2022	Amortized Cost		Gross Unrealized Gains		Gross Unrealized Losses		Fair Market Value
Cash and cash equivalents	N/A		N/A		N/A		$	145,924
Current restricted cash	N/A		N/A		N/A		700
Cash, cash equivalents, and restricted cash as reported within the Consolidated Statements of Cash Flows	N/A		N/A		N/A		146,624
Marketable investments - U.S. Treasury	171,484		8		(102)		171,390
Total	$	171,484	$	8	$	(102)	$	318,014